{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:21:42Z","timestamp":1762338102872,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Nihon Gakujutsu Shinkokai","doi-asserted-by":"publisher","award":["20K17181"],"award-info":[{"award-number":["20K17181"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rmed.2025.108027","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:44:13Z","timestamp":1741031053000},"page":"108027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reduction in circulating Endothelin-1 levels by inhaled COPD medications"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-1280","authenticated-orcid":false,"given":"Hiroki","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratoe","family":"Suraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Hazama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanoko","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9401-466X","authenticated-orcid":false,"given":"Naoko","family":"Katsurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Tachihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-2616","authenticated-orcid":false,"given":"Noriaki","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3115-8797","authenticated-orcid":false,"given":"Kazuyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108027_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2025.108027_bib2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108027_bib3","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2025.108027_bib4","unstructured":"Classification and pathophysiology of pulmonary hypertension n.d. https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/cce2.71 (accessed June 10, 2024)."},{"key":"10.1016\/j.rmed.2025.108027_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00370-2019","article-title":"Pulmonary vascular density: comparison of findings on CT imaging with histology","volume":"54","author":"Rahaghi","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108027_bib6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/resp.12772","article-title":"Pulmonary vasculature in COPD: the silent component","volume":"21","author":"Blanco","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2025.108027_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/thx.36.10.752","article-title":"Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease","volume":"36","author":"Weitzenblum","year":"1981","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2025.108027_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108027_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00018-010-0518-0","article-title":"Endothelin","volume":"68","author":"Kawanabe","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.rmed.2025.108027_bib10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.cellsig.2010.05.002","article-title":"Endothelin\u2014biology and disease","volume":"22","author":"Khimji","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.rmed.2025.108027_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1096\/fj.10-161612","article-title":"Endothelin\u20101 gene regulation","volume":"25","author":"Stow","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.rmed.2025.108027_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.rmed.2025.108027_bib13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib14","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2025.108027_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2025.108027_bib17","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1183\/09031936.97.10092055","article-title":"Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise","volume":"10","author":"Yamakami","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108027_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2466-8-20","article-title":"Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension","volume":"8","author":"Carratu","year":"2008","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/690017","article-title":"Chronic use of PAH-specific therapy in world health organization group III pulmonary hypertension: a systematic review and meta-analysis","volume":"7","author":"Prins","year":"2017","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.rmed.2025.108027_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3346\/jkms.2013.28.8.1200","article-title":"Systematic review and meta-analysis of pulmonary hypertension specific therapy for exercise capacity in chronic obstructive pulmonary disease","volume":"28","author":"Park","year":"2013","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.rmed.2025.108027_bib21","first-page":"309","article-title":"Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis","volume":"7","author":"Chen","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.rmed.2025.108027_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.resinv.2023.08.007","article-title":"Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition)","volume":"61","author":"Shibata","year":"2023","journal-title":"Respiratory Investigation"},{"key":"10.1016\/j.rmed.2025.108027_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-2600(23)00461-7","article-title":"GOLD COPD report: 2024 update","volume":"12","author":"Venkatesan","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12931-021-01659-2","article-title":"Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells","volume":"22","author":"Yang","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib26","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1111\/bph.13143","article-title":"The long\u2010acting \u03b2 2 \u2010adrenoceptor agonist olodaterol attenuates pulmonary inflammation","volume":"172","author":"Wex","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108027_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.intimp.2013.12.021","article-title":"Inhalation of glycopyrronium inhibits cigarette smoke-induced acute lung inflammation in a murine model of COPD","volume":"18","author":"Shen","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.rmed.2025.108027_bib28","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/COPD.S113176","article-title":"Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD","volume":"11","author":"Soltani","year":"2016","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2025.108027_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12931-015-0262-y","article-title":"Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells","volume":"16","author":"Price","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1183\/09031936.00146610","article-title":"Tiotropium inhibits pulmonary inflammation and remodelling in a Guinea pig model of COPD","volume":"38","author":"Pera","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108027_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12931-022-02081-y","article-title":"Budesonide\/glycopyrronium\/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NF\u03baB inactivation","volume":"23","author":"Suraya","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12931-019-0975-4","article-title":"Phospholipase C\u03b5 plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells","volume":"20","author":"Umezawa","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.rmed.2025.108027_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1152\/japplphysiol.00641.2015","article-title":"Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation","volume":"120","author":"Gras","year":"2016","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2025.108027_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Galie","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/rr44","article-title":"Role of endothelin-1 in lung disease","volume":"2","author":"Fagan","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107658","article-title":"Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH","volume":"227","author":"Choudhury","year":"2024","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.rmed.2005.08.022","article-title":"Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease","volume":"100","author":"Hacievliyagil","year":"2006","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108027_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s001340100882","article-title":"Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor \u03baB dependent mechanism","volume":"27","author":"Dschietzig","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.rmed.2025.108027_bib40","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115367","article-title":"Hypoxia induces endothelin gene expression and secretion in cultured human endothelium","volume":"88","author":"Kourembanas","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.rmed.2025.108027_bib41","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1164\/ajrccm\/141.4_Pt_1.895","article-title":"Lung structure and gas exchange in mild chronic obstructive pulmonary disease","volume":"141","author":"Barbera","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2025.108027_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1399-6576.2007.01277.x","article-title":"Low concentrations of inhaled nitric oxide do not improve oxygenation in patients with very severe chronic obstructive pulmonary disease","volume":"51","author":"Melsom","year":"2007","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.rmed.2025.108027_bib43","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1164\/rccm.201805-0995OC","article-title":"Effect of indacaterol\/glycopyrronium on pulmonary perfusion and ventilation in hyperinflated patients with chronic obstructive pulmonary disease (claim). A double-blind, randomized, crossover trial","volume":"199","author":"Vogel-Claussen","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108027_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1465-9921-10-7","article-title":"Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model","volume":"10","author":"L\u00fcthje","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108027_bib45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/jappl.2000.88.4.1327","article-title":"Functional, cellular, and biochemical adaptations to elastase-induced emphysema in hamster medial scalene","volume":"88","author":"Fournier","year":"2000","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2025.108027_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1183\/09031936.00085612","article-title":"Haemodynamic responses to exercise in patients with COPD","volume":"41","author":"Hilde","year":"2013","journal-title":"Eur. Respir. J."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:17:24Z","timestamp":1762337844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"alternative-id":["S0954611125000897"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108027","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in circulating Endothelin-1 levels by inhaled COPD medications","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108027"}}